June 26 (Reuters) - AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage ...
Megarounds have been few and far between in 2024, but Formation Bio has managed to draw in an impressive $372 million series D as the AI-focused biotech seeks to expand its pipeline. AI companies like ...
Eli Lilly and Company (NYSE: LLY) said on Tuesday that it is collaborating with Microsoft (MSFT) backed-OpenAI that will help leverage generative AI to invent novel antimicrobials to treat ...